The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Size Of The Lung Cancer Surgery Equipment Market Progress Through 2030?
The lung cancer surgery equipment market size has experienced strong growth in recent years. It is projected to expand from $3.73 billion in 2025 to $3.98 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be ascribed to factors such as the limited availability of advanced thoracic surgery equipment, a reliance on traditional open surgeries, the increasing prevalence of lung cancer, a rising number of hospital and surgical clinics, and the adoption of standard biopsy and imaging procedures.
The lung cancer surgery equipment market is projected for significant expansion over the coming years. This market is anticipated to reach $5.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This projected growth is driven by several factors, including the advancement of robotic-assisted and minimally invasive surgical instruments, the incorporation of AI-powered imaging and monitoring technologies, increased funding for research and academic institutions, the wider implementation of Enhanced Recovery After Surgery (ERAS) guidelines, and the establishment of more specialized centers for lung cancer treatment. Key trends anticipated during this period involve the increasing popularity of minimally invasive lung procedures, a heightened need for sophisticated imaging and diagnostic tools, the integration of patient monitoring systems with surgical devices, a greater emphasis on postoperative rehabilitation and follow-up care, and the spread of robotic-assisted thoracic surgical techniques.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24594&type=smp
Which Major Factors Are Contributing To The Development Of The Lung Cancer Surgery Equipment Market?
The increasing incidence of lung cancer is anticipated to fuel expansion in the lung cancer surgery equipment market in the foreseeable future. This condition involves the unchecked proliferation of aberrant cells within the lungs, frequently linked to tobacco use or detrimental environmental factors. The uptick in lung cancer diagnoses is primarily attributable to elevated exposure to risk factors like tobacco smoke, atmospheric contaminants, and workplace carcinogens, alongside a demographic shift towards an older population. Tools for lung cancer surgery serve to identify the disease, excise malignant tissue, and aid in recovery after operations via accurate surgical procedures and continuous patient observation. As an illustration, in February 2025, the Cancer Council, an Australian non-profit body, reported that approximately 15,122 people were diagnosed with lung cancer in Australia during 2024, with the typical age at diagnosis being 72. In Australia, lung cancer stands as the fifth most frequently diagnosed malignancy, and roughly one in 20 Australians is projected to receive such a diagnosis by the age of 85. Consequently, the expanding occurrence of lung cancer is propelling the development of the lung cancer surgery equipment market.
How Are Different Segment Groups Identified Within The Lung Cancer Surgery Equipment Market?
The lung cancer surgery equipment market covered in this report is segmented –
1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment
2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery
3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation
4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes
Subsegments:
1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures
2) By Access Devices: Trocars, Catheters, Guidewires, Introducers
3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices
4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems
5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices
6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors
Which Trends Are Influencing The Direction Of The Lung Cancer Surgery Equipment Market?
Leading companies in the lung cancer surgery equipment market are concentrating on developing devices for robotically assisted bronchoscopy. This focus aims to boost the precision and safety of tumor localization and biopsy, enhance access to hard-to-reach lung nodules, and support the early and accurate diagnosis of lung cancer. Robotically assisted bronchoscopy is an advanced medical procedure that utilizes robotic technology to guide a bronchoscope, a thin, flexible tube, into the lungs with greater precision and control than traditional manual techniques. For instance, in March 2025, Johnson and Johnson, a US-based pharmaceutical company, announced that its MONARCH QUEST system, a sophisticated robotic-assisted bronchoscopy technology, had received U.S. FDA 510(k) clearance. This system marks the latest evolution of the MONARCH Platform, which is engineered to improve the diagnosis of lung cancer through minimally invasive procedures. The system interfaces with the GE HealthCare OEC 3D mobile CBCT Imaging System, facilitating real-time, intraprocedural 3D imaging. This integration significantly improves the precision of targeting lung nodules, especially those located in difficult-to-access areas of the lung.
Who Are The Major Companies Operating In The Lung Cancer Surgery Equipment Market?
Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, Ambu A S
Access The Complete Lung Cancer Surgery Equipment Market Report:
https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report
Which Region Has The Strongest Presence In The Lung Cancer Surgery Equipment Market?
North America was the largest region in the lung cancer surgery equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Lung Cancer Surgery Equipment Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report
Browse Through More Reports Similar to the Global Lung Cancer Surgery Equipment Market 2026, By The Business Research Company
Lung Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report
Thoracic Surgery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/thoracic-surgery-devices-global-market-report
Surgical Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/surgical-equipment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model